Post Study Continuation of C7 for G1D

N/ANo Longer AvailableNCT02018302

Juan Pascual

Overview

This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.

Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only.

Study Type

EXPANDED_ACCESS

Conditions

Glut1 Deficiency Syndrome Glucose Transporter Type 1 Deficiency Syndrome

Interventions

TriheptanoinDRUG

Eligibility

Sex: ALLMin age: 1 MonthMax age: 28 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients enrolled in the pilot trial (UTSW 122010-186) Exclusion Criteria: * Subjects who did not complete the pilot trial (UTSW 122010-186)

Locations (1)

UT Southwestern Medical Center

Dallas, Texas, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.